Jinlida granules ameliorate the high-fat-diet induced liver injury in mice by antagonising hepatocytes pyroptosis-Reference-Cited by-同舟云学术

Jinlida granules ameliorate the high-fat-diet induced liver injury in mice by antagonising hepatocytes pyroptosis

Published:2022-02-09 Issue:1 Volume:60 Page:274-281
ISSN:1388-0209
Container-title:Pharmaceutical Biology
language:en
Short-container-title:Pharmaceutical Biology

Author:

Hao Yuan-yuan¹^ORCID,Cui Wen-wen¹²^ORCID,Gao Huai-lin¹³^ORCID,Wang Ming-ye¹^ORCID,Liu Yan⁴^ORCID,Li Cui-ru¹⁵^ORCID,Hou Yun-long¹²^ORCID,Jia Zhen-hua³⁵^ORCID

Affiliation:

1. College of Integrative Medicine, Hebei University of Chinese Medicine, Hebei, China

2. Hebei Yiling Pharmaceutical Research Institute, Hebei, China

3. Hebei Yiling Hospital, Hebei, China

4. Xianghe Hospital of Traditional Chinese Medicine, Hebei, China

5. National Key Laboratory of Luobing Research and Innovative Chinese Medicine, Hebei, China

Funder

National Key Research and Development Program of China

Publisher

Informa UK Limited

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13880209.2022.2029501

Reference40 articles.

1. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation

2. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

3. Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease

4. Deficiency of the Purinergic Receptor 2X7 Attenuates Nonalcoholic Steatohepatitis Induced by High-Fat Diet: Possible Role of the NLRP3 Inflammasome

5. Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of epigallocatechin gallate in treating non-alcoholic fatty liver disease: Insights from network pharmacology and experimental validation;Biochemical and Biophysical Research Communications;2024-11

2. Targeting cell death in NAFLD: mechanisms and targeted therapies;Cell Death Discovery;2024-09-07

3. JinLiDa granules alleviates cardiac hypertrophy and inflammation in diabetic cardiomyopathy by regulating TP53;Phytomedicine;2024-07

4. Asprosin aggravates nonalcoholic fatty liver disease via inflammation and lipid metabolic disturbance mediated by reactive oxygen species;Drug Development Research;2024-05-27

5. Exploring the mechanism of Jinlida granules against type 2 diabetes mellitus by an integrative pharmacology strategy;Scientific Reports;2024-05-04